Skip to main content

A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation: The AEIOU Trial.

Author
Abstract
:

This study sought to determine whether uninterrupted apixaban would have similar rates of bleeding and thromboembolic events as does minimally interrupted apixaban at the time of atrial fibrillation (AF) ablation and to compare those results with rates in historical patients treated with uninterrupted warfarin.

Year of Publication
:
2018
Journal
:
JACC. Clinical electrophysiology
Volume
:
4
Issue
:
5
Number of Pages
:
580-588
ISSN Number
:
2405-500X
URL
:
https://linkinghub.elsevier.com/retrieve/pii/S2405-500X(17)31089-7
DOI
:
10.1016/j.jacep.2017.11.005
Short Title
:
JACC Clin Electrophysiol
Download citation